1. Home
  2. Category
  3. Symptoms/Side Effects

Cognitive Impairment

Online Exclusive Article

Assessing Discrepancies in Neurocognitive and Patient-Reported Measures of Brain Tumor Survivors

Deborah “Hutch” Allen
Barbara W. Carlson
John R. Carlson
Renee H. Raynor
Virginia J. Neelon
ONF 2020, 47(1), E1-E12 DOI: 10.1188/20.ONF.E1-E12
Objectives: To examine the association between performance-based neurocognitive and patient-reported cognitive function tests and identify characteristics that may explain observed discrepancies as a means to advance intervention development. Sample & Setting: 40 adults diagnosed with a primary...
0
No votes yet
Read this Article
Article

Individualized Piano Instruction for Improving Cognition in Breast Cancer Survivors

Marlen Rodriguez-Wolfe
Debbie Anglade
Karina A. Gattamorta
William B. Hurwitz
William F. Pirl
ONF 2019, 46(5), 605-615 DOI: 10.1188/19.ONF.605-615
Purpose: To evaluate the use of individualized piano instruction (IPI) for improving cognition among breast cancer survivors. Participants & Setting: Six participants were included in an eight-week piano program with three data collection time points at baseline, midpoint, and postintervention...
0
No votes yet
Read this Article
NCPD Article

Chemobrain: A Pilot Study Exploring the Severity and Onset of Chemotherapy-Related Cognitive Impairment

Kelly Moore
Sonja Stutzman
Laurin Priddy
DaiWai Olson
CJON 2019, 23(4), 411-416 DOI: 10.1188/19.CJON.411-416
Background: Chemotherapy-related cognitive impairment refers to a cluster of symptoms commonly referred to as “chemobrain”. To date, nursing literature on the progression of and tools used to evaluate chemobrain is limited. Objectives: The purpose of this pilot study was to explore the onset of...
5
Average: 5 (1 vote)
Read this Article
Advanced Practice

Neurologic Complications: Effects of Ipilimumab and Nivolumab Therapy in Patients With Metastatic Melanoma

Jessica Latchman
Ann Guastella
Cindy Tofthagen
CJON 2019, 23(4), 355-358 DOI: 10.1188/19.CJON.355-358
Checkpoint inhibitors are a form of immunotherapy that have revolutionized treatment for malignant melanoma, resulting in longer survival and better disease control. Multiple autoimmune disorders can occur with the use of checkpoint inhibitors, including severe, potentially fatal neurologic...
5
Average: 5 (1 vote)
Read this Article
Clinical Challenges

Postchemotherapy Confusion

Sheryl L. Stewart
ONF 2001, 1361-1362 DOI:
Ms. M is a 31-year-old female with metastatic osteogenic sarcoma. She has received multiple chemotherapeutic agents in the past, including cisplatin, and has experienced periodic disease-free intervals. She has no evidence of abdominal disease and no prior nephrectomy.
0
No votes yet
Read this Article

Questions, Concerns or Requests

We're just a click away for assistance.